| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |